愛慕股份(603511.SH):旗下愛慕健康品牌現已開發並上市女性衛生巾產品
格隆匯7月8日丨愛慕股份(603511.SH)在互動平臺表示,公司旗下愛慕健康品牌現已開發並上市女性衛生巾產品,因此本次公司經營範圍新增”衛生用品和一次性使用醫療用品銷售、第一類醫療器械銷售”。公司研發技術和產品並未涉及海蜇膠原蛋白提取專利技術、深海細菌纖維素量產工藝(中試驗證階段) 燒傷敷料關鍵材料、牡蠣肽促傷口癒合技術(臨牀II期) 替代抗生素的抗菌敷料。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.